FDA gives green light to Vysioneer's brain tumor autocontouring tool

Updated

Vbrain is a neural network-based AI solution, trained from clinical data. The software-only solution is "vendor neutral and can be seamlessly integrated into any treatment planning system."

Vysioneer tested the software in multiple sites in the U.S. and Taiwan. The tool was also evaluated through an 18-month collaboration with National Taiwan University Hospital (NTUH). Those results, published last month in Neuro-Oncology, found that Vbrain had a 12.2% higher sensitivity for lesion detection than unassisted physicians and that less-experienced clinicians improved their contouring accuracy with the software's help. Vbrain also increased workflow efficiency, reducing treatment planning time by a median of 30.8%.

【MORE】